A study found that sonodynamic therapy showed no adverse events and demonstrated cancer cell death in 3 patients with ...
Plus Therapeutics, Inc. (Nasdaq: PSTV) (the "Company” or "Plus Therapeutics”), a clinical-stage pharmaceutical company ...
Plus Therapeutics, Inc. (Nasdaq: PSTV) (the "Company" or "Plus Therapeutics"), a clinical-stage pharmaceutical company developing targeted radiotherapeutics ...
Cash on hand provides over one year of runway to fund expected operations HOUSTON, TX / ACCESS Newswire / February 26, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopha ...
A New Drug Application has been accepted seeking accelerated approval for dordaviprone for patients with recurrent H3 ...
AZoLifeSciences on MSN3h
RNA Splicing Errors May Hold the Key to Beating Gliomas Using ImmunotherapyIdentifying splicing-related neoantigens in gliomas opens new avenues for immunotherapy, enhancing treatment strategies for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback